Pegunigalsidase alfa

Decision Date:
November 2023


RED: NICE TA915Pegunigalsidase alfa for treating Fabry disease. NHSE commissioned (Decision date - November 2023)

Red Drug Classifications

  • 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
  • 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app